DR REDDYS LABORATORIES LTD
About DR REDDYS LABORATORIES LTD
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company in North America, Europe, India, Russia, and internationally. The company offers products across therapeutic categories including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, and pain management. It was incorporated in 1984 and is headquartered in Hyderabad, India. It operates through Global Generics, Pharmaceutical Services and Active Ingredients, and Proprietary Products segments.
Investors
Not disclosed in the source filing. Form D filings do not list investors — StreetZero surfaces them from news where available.
Key highlights
- Completed US IPO of $132.8 million in 2001 listed on NYSE.
- Operates integrated pharma business across multiple continents and therapeutic areas.
- Maintains strong balance sheet with net cash surplus as of late 2025.
- Invests in R&D for differentiated formulations and branded products.
Ask StreetZero about DR REDDYS LABORATORIES LTD
Put our AI to work on this deal.
Similar companies
Other Public Equity (NYSE) deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account